Diabetes mellitus, commonly known as diabetes, is a group of metabolic diseases in which blood sugar levels goes extremely high over a prolonged period. Antidiabetics are the medicines developed to stabilize and control blood glucose (sugar) levels amongst diabetes patient. Antidiabetic drugs are generally used to control diabetes. Insulin pramlintide (Amylin), GLP-1 receptor agonists such as Byetta and Victoza are the different types of antidiabetics drugs. The global antidiabetics market is driven by increasing prevalence of diabetes mellitus.
Request Sample Report @ http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=51861
The report provides a comprehensive view on the antidiabetics; we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the antidiabetics market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate, and general attractiveness.
Do Inquiry before buying @ http://www.syndicatemarketresearch.com/market-analysis/antidiabetics-market.html#inquiry-for-buying
The global antidiabetics market is segmented on the basis of product and region. The product segments of the global antidiabetics market include insulin, rapid-acting, long-acting, premixed, premixed analog, short acting, intermediate acting, antidiabetics, alpha-glucosidase inhibitors, biguanides, sulphonylureas, glp-1 agonist, meglitinides, dpp-4 inhibitors, salt – 2 and thiazolidinediones. Insulin dominated the overall market in terms of revenue.
Major regional segments analyzed in this study include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, further bifurcation of a region on the country level, which includes U.S., Germany, UK, France, China, Japan and India. North America dominated antidiabetics market.
Browse the full report @ http://www.syndicatemarketresearch.com/market-analysis/antidiabetics-market.html
Some of the key players for global antidiabetics market include Boehringer Ingelheim GmbH, Astra Zeneca plc, Eli Lilly & Co., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, SanofiS.A., Johnson & Johnson, Mankind Pharma Ltd., and Teva Pharmaceutical Industries Ltd.
Key segments of the Global Antidiabetics Market
Global Antidiabetics Market: Product Segment Analysis
- Long acting
- Premixed analog
- Short acting
- Alpha-glucosidase inhibitors
- GLP-1 agonist
- DPP-4 inhibitors
- SGLT – 2
Global Antidiabetics Market: Region Segment Analysis
- North America
- Latin America
- The Middle East & Africa